Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2011

View Archived Issues

Serum KL-6 level is a biomarker of prognosis in diffuse alveolar hemorrhage syndrome

Genmab provides pipeline and technology update

Interim phase II data disclosed on nimotuzumab plus irinotecan in gastric cancer

StronBone Sr-substituted bioactive glass implants show promise in bone grafting

Phase I data reported on recombinant angiotensin-converting enzyme 2

Flex-590 confers chondroprotection in a model of osteoarthritis

AMG-369 reduces severity of experimental autoimmune encephalomyelitis

AstraZeneca responds to FDA complete response letter for Brilinta

CHMP issues positive opinion on Eisai's Halaven for metastatic breast cancer

Cytori Therapeutics' ADVANCE trial of ADRCs is cleared to begin in the Netherlands

New blockers of cyclic nucleotide-regulated HCN1 channel claimed

PGxHealth presents new adenosine A2A receptor agonists

Novartis receives Swiss and Austrian approval for Gilenya in relapsing-remitting MS

CHMP recommends European marketing authorization for Trobalt

R-Tech Ueno completes phase IIa RK-023 trial in androgenetic alopecia

CHMP recommends new indications of INOmax

New melanin-concentrating hormone MCH1 receptor antagonists claimed

FDA grants priority review for Optimer Pharma's fidaxomicin NDA

Enrollment complete in pivotal phase III trial of delayed-release cysteamine

Novel PI3K inhibitors described at Novartis

FDA approves Viibryd for major depressive disorder

Otuska submits application to extend indication for Abilify in Japan

FDA recommends approval of Bayer's gadobutrol injection

Eisai decides against submitting marketing applications for eritoran for severe sepsis

Eisai set to submit U.S. and E.U. marketing authorization applications for perampanel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...